CNTA
Price
$16.63
Change
-$0.12 (-0.72%)
Updated
Feb 21 closing price
Capitalization
2.19B
32 days until earnings call
IMNM
Price
$9.52
Change
-$0.59 (-5.84%)
Updated
Feb 21 closing price
Capitalization
806.11M
31 days until earnings call
Ad is loading...

CNTA vs IMNM

Header iconCNTA vs IMNM Comparison
Open Charts CNTA vs IMNMBanner chart's image
Centessa Pharmaceuticals
Price$16.63
Change-$0.12 (-0.72%)
Volume$755.95K
Capitalization2.19B
Immunome
Price$9.52
Change-$0.59 (-5.84%)
Volume$674.08K
Capitalization806.11M
CNTA vs IMNM Comparison Chart
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTA vs. IMNM commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a Hold and IMNM is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (CNTA: $16.63 vs. IMNM: $9.52)
Brand notoriety: CNTA and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 105% vs. IMNM: 67%
Market capitalization -- CNTA: $2.19B vs. IMNM: $806.11M
CNTA [@Biotechnology] is valued at $2.19B. IMNM’s [@Biotechnology] market capitalization is $806.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, CNTA is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 3 bullish TA indicator(s).

  • CNTA’s TA Score: 4 bullish, 6 bearish.
  • IMNM’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CNTA is a better buy in the short-term than IMNM.

Price Growth

CNTA (@Biotechnology) experienced а -2.58% price change this week, while IMNM (@Biotechnology) price change was -8.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

CNTA is expected to report earnings on May 19, 2025.

IMNM is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTA($2.19B) has a higher market cap than IMNM($806M). CNTA YTD gains are higher at: -0.716 vs. IMNM (-10.358). IMNM has higher annual earnings (EBITDA): -109.95M vs. CNTA (-147.19M). CNTA has more cash in the bank: 518M vs. IMNM (240M). IMNM has less debt than CNTA: IMNM (2.72M) vs CNTA (84.7M). IMNM has higher revenues than CNTA: IMNM (10.1M) vs CNTA (6.85M).
CNTAIMNMCNTA / IMNM
Capitalization2.19B806M272%
EBITDA-147.19M-109.95M134%
Gain YTD-0.716-10.3587%
P/E RatioN/AN/A-
Revenue6.85M10.1M68%
Total Cash518M240M216%
Total Debt84.7M2.72M3,113%
TECHNICAL ANALYSIS
Technical Analysis
CNTAIMNM
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 6 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CDDYX35.32-0.34
-0.95%
Columbia Dividend Income Inst3
EILGX18.48-0.18
-0.96%
Eaton Vance Atlanta Capital Focused Gr I
CIOAX17.25-0.17
-0.98%
Calvert International Opportunities A
JLPZX17.43-0.37
-2.08%
JPMorgan US Large Cap Core Plus R2
MIOFX26.27-0.67
-2.49%
Marsico International Opportunities

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-0.72%
VCYT - CNTA
37%
Loosely correlated
-4.56%
IMNM - CNTA
35%
Loosely correlated
-5.84%
XENE - CNTA
35%
Loosely correlated
+0.89%
FULC - CNTA
34%
Loosely correlated
N/A
KYMR - CNTA
32%
Poorly correlated
-1.63%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-5.84%
KYMR - IMNM
49%
Loosely correlated
-1.63%
IDYA - IMNM
49%
Loosely correlated
+0.55%
FATE - IMNM
48%
Loosely correlated
-8.09%
RXRX - IMNM
47%
Loosely correlated
-10.34%
BEAM - IMNM
47%
Loosely correlated
-8.18%
More